The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
Open accessAbstract
Objective: To investigate the synovial tissue in patients with rheumatoid arthritis (RA) treated with rituximab and to identify possible predictors of clinical response. Methods: A total of 24 patients with RA underwent synovial biopsy before, 4 and 16 weeks after initiation of rituximab treatment (without peri-infusional corticosteroids to prevent bias). Immunohistochemical analysis was performed and stained sections were analysed by digital image analysis. Linear regression analysis was used to identify predictors of clinical response. Results: The 28-joint Disease Activity Score (DAS28) was unaltered at 4 weeks, but significantly reduced at 16 and 24 weeks. Serum levels of IgM-rheumatoid factor (RF) decreased significantly at 24 weeks and anti-citrullinated peptide antibody (ACPA) levels at 36 weeks. Peripheral blood B cells were depleted at 4 weeks and started to return at 24 weeks. Synovial B cells were significantly decreased at 4 weeks, but were not completely depleted in all patients; there was a further reduction at 16 weeks in some patients. We found a significant decrease in macrophages at 4 weeks, which was more pronounced at 16 weeks. At that timepoint, T cells were also significantly decreased. The reduction of plasma cells predicted clinical improvement at 24 weeks. Conclusions: The results support the view that B cells orchestrate local cellular infiltration. The kinetics of the serological as well as the tissue response in clinical responders are consistent with the notion that rituximab exerts its effects in part by an indirect effect on plasma cells associated with autoantibody production, which could help explain the delayed response after rituximab treatment. Trial registration number: ISRCTN05568900.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G., Cravets, M. W., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22025 · Cited by 1,638
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R. F., Li, N. F., Agarwal, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,060
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k · Cited by 803
T Cell Activation in Rheumatoid Synovium Is B Cell Dependent
Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4710 · Cited by 536
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
Cambridge, G., Leandro, M. J., Edwards, J. C. W., Ehrenstein, M. R., Salden, M., Bodman‐Smith, M., & Webster, A. D. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11181 · Cited by 470
Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., & Tak, P. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029751 · Cited by 457
Self-citationManzo, A., Paoletti, S., Carulli, M., Blades, M. C., Barone, F., Yanni, G., FitzGerald, O., Bresnihan, B., Caporali, R., Montecucco, C., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425830 · Cited by 251
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
Smolen, J. S., Keystone, E. C., Emery, P., Breedveld, F. C., Betteridge, N., Burmester, G. R., Dougados, M., Ferraccioli, G., Jaeger, U., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061002 · Cited by 228
Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis
Vos, K., Thurlings, R. M., Wijbrandts, C. A., van Schaardenburg, D., Gerlag, D. M., & Tak, P. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22400 · Cited by 194
Self-citationRegulatory Roles for Cytokine- Producing B Cells in Infection and Autoimmune Disease
Lund, F. E., Garvy, B. A., Randall, T. D., & Harris, D. P. (2004) · Current Directions in Autoimmunity · doi:10.1159/000082086 · Cited by 181
Kavanaugh, A., Rosengren, S., Lee, S. J., Hammaker, D., Firestein, G. S., Kalunian, K., Wei, N., & Boyle, D. L. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074229 · Cited by 178
Do self‐perpetuating B lymphocytes drive human autoimmune disease?
Edwards, Cambridge, & Abrahams (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00772.x · Cited by 174
Kraan, M. C., Reece, R. J., Smeets, T. J. M., Veale, D. J., Emery, P., & Tak, P. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10556 · Cited by 158
Self-citationGerlag, D. M., Haringman, J. J., Smeets, T. J. M., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20664 · Cited by 156
Self-citationSmeets, T. J. M., Barg, E. C., Kraan, M. C., Smith, M. D., Breedveld, F. C., & Tak, P. P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.635 · Cited by 150
Self-citationFollicular Dendritic Cells Specifically Express the Long CR2/CD21 Isoform
Liu, Y.-J., Xu, J., de BOUTEILLER, O., Parham, C. L., Grouard, G., Djossou, O., de Saint-Vis, B., Lebecque, S., Banchereau, J., & Moore, K. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.165 · Cited by 139
Quantitative biomarker analysis of synovial gene expression by real-time PCR
Boyle, D. L., Rosengren, S., Bugbee, W. D., Kavanaugh, A., & Firestein, G. S. (2003) · Arthritis Research & Therapy · doi:10.1186/ar1004 · Cited by 136
Quantification of the cell infiltrate in synovial tissue by digital image analysis
Kraan, M. C., Haringman, J. J., Ahern, M. J., Breedveld, F. C., Smith, M., & Tak, P. P. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.1.43 · Cited by 133
Self-citationKrzysiek, R., Lefèvre, E. A., Zou, W., Foussat, A., Bernard, J., Portier, A., Galanaud, P., & Richard, Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4455 · Cited by 133
Abrahams, V. M., Cambridge, G., Lydyard, P. M., & Edwards, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<608::aid-anr18>3.0.co;2-g · Cited by 131
Krzysiek, R., Lefèvre, E. A., Zou, W., Foussat, A., Bernard, J., Portier, A., Galanaud, P., & Richard, Y. (1999) · PubMed · Cited by 123
B Lymphocyte-Derived IL-16 Attracts Dendritic Cells and Th Cells
Kaser, A., Dunzendorfer, S., Offner, F. A., Ludwiczek, O., Enrich, B., Koch, R., Cruikshank, W. W., Wiedermann, C. J., & Tilg, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2474 · Cited by 96
William, J., Euler, C. W., & Shlomchik, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6879 · Cited by 95
Haringman, J. J., Vinkenoog, M., Gerlag, D. M., Smeets, T. J. M., Zwinderman, A. H., & Tak, P. P. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1757 · Cited by 76
Self-citationTerui, Y., Sakurai, T., Mishima, Y. M., Mishima, Y., Sugimura, N., Sasaoka, C., Kojima, K., Yokoyama, M., Mizunuma, N., Takahashi, S., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2006.00139.x · Cited by 65
Lymphotoxin β–mediated stimulation of synoviocytes in rheumatoid arthritis
Braun, A. B., Takemura, S., Vallejo, A. N., Goronzy, J. J., & Weyand, C. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20356 · Cited by 60
Synovial tissue response to treatment with campath‐1h
Ruderman, E., Weinblatt, M. E., Thurmond, L. M., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380215 · Cited by 54
Analysis of cell populations in rheumatoid arthritis synovial tissues
Yanni, G., Whelan, A., Feighery, C., & Bresnihan, B. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90040-k · Cited by 42
Cited by
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Neutrophil function in inflammation and inflammatory diseases
Wright, H. L., Moots, R. J., Bucknall, R. C., & Edwards, S. W. (2010) · Rheumatology · doi:10.1093/rheumatology/keq045 · Cited by 761
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144998 · Cited by 453
Self-citation
Metadata
- Authors
- Thurlings, R. M., Vos, K., Wijbrandts, C. A., Zwinderman, A. H., Gerlag, D. M., & Tak, P. P.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 67
- Issue
- 7
- Pages
- 917-925
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W1985380203
- Cited by
- 334
- References
- 32
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.